A University of Sheffield researcher has uncovered new evidence that could help improve treatment options for patients with ...

"It was 10 months into his treatment when I finally broke in front of him, and he revealed the surprising yet profound truth ...

Fresh figures published today by NHS England reveal that annual mouth cancer diagnoses in England have climbed to 9,293 – representing a 37% rise over the last decade. Fatalities have also increased, ...

Throat cancer represents one of the most treatable forms of cancer when caught early, yet thousands of cases go undiagnosed until advanced stages because symptoms often masquerade as common, harmless ...

According to a new report, cancer rates are skyrocketing in this tiny country. What's causing this to happen? And what steps can be taken to turn... This nation has the fastest rising rate of cancer ...

Ali Mokdad stands in the heart of Beirut. Cars and trucks and motorcycles rumble everywhere. "If you look at a car passing by, you see smoke coming out of it — that's illegal in Lebanon. But nobody ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

A new drug combination may benefit men whose prostate cancer has returned after primary surgery or radiation therapy. Pairing enzalutamide, an androgen receptor blocker, with the hormone therapy drug ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...